Takeda And Alnylam Highlight Keys To Successful Negotiation And Collaboration At BIO Conference
This article was originally published in The Pink Sheet Daily
Executive Summary
Alnylam's Rhodes, Takeda's Weitz recap how the companies came together.
You may also be interested in...
RNAi Giant Alnylam Says Alliances with Japanese Pharmas Well Underway
TOKYO - An executive from Massachusetts-based biotech Alnylam says its RNAi alliances with Takeda and Kyowa Hakko Kirin are well underway
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.